| Key Financial Ratios of Torrent Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
55.79 |
40.10 |
31.07 |
58.59 |
67.24 |
|
| Diluted EPS (Rs.) |
55.79 |
40.10 |
31.07 |
58.59 |
67.24 |
|
| Cash EPS (Rs.) |
78.22 |
62.58 |
50.93 |
94.18 |
103.27 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
224.32 |
201.76 |
190.75 |
374.94 |
356.30 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
224.32 |
201.76 |
190.75 |
374.94 |
356.30 |
|
| Dividend / Share(Rs.) |
32.00 |
28.00 |
22.00 |
48.00 |
35.00 |
|
| Revenue from Operations/Share (Rs.) |
286.07 |
252.11 |
227.36 |
398.39 |
381.15 |
|
| PBDIT/Share (Rs.) |
106.58 |
88.07 |
75.25 |
136.19 |
136.50 |
|
| PBIT/Share (Rs.) |
84.14 |
65.58 |
55.39 |
100.60 |
100.46 |
|
| PBT/Share (Rs.) |
77.12 |
56.63 |
46.59 |
86.63 |
80.72 |
|
| Net Profit/Share (Rs.) |
55.78 |
40.10 |
31.06 |
58.58 |
67.23 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
37.25 |
34.93 |
33.09 |
34.18 |
35.81 |
|
| PBIT Margin (%) |
29.41 |
26.01 |
24.36 |
25.25 |
26.35 |
|
| PBT Margin (%) |
26.95 |
22.46 |
20.49 |
21.74 |
21.17 |
|
| Net Profit Margin (%) |
19.49 |
15.90 |
13.66 |
14.70 |
17.63 |
|
| Return on Networth / Equity (%) |
24.86 |
19.87 |
16.28 |
15.62 |
18.86 |
|
| Return on Capital Employed (%) |
28.87 |
23.64 |
19.81 |
19.50 |
18.53 |
|
| Return on Assets (%) |
14.70 |
10.96 |
8.16 |
8.88 |
9.67 |
|
| Total Debt/Equity (X) |
0.34 |
0.49 |
0.71 |
0.53 |
0.73 |
|
| Asset Turnover Ratio (%) |
0.77 |
0.68 |
0.64 |
0.59 |
0.55 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.46 |
1.25 |
1.15 |
1.68 |
1.60 |
|
| Quick Ratio (X) |
0.94 |
0.73 |
0.68 |
0.93 |
0.86 |
|
| Inventory Turnover Ratio (X) |
6.07 |
1.04 |
0.87 |
0.82 |
0.83 |
|
| Dividend Payout Ratio (NP) (%) |
57.36 |
74.81 |
82.08 |
68.27 |
29.74 |
|
| Dividend Payout Ratio (CP) (%) |
40.90 |
47.93 |
50.06 |
42.46 |
19.36 |
|
| Earnings Retention Ratio (%) |
42.64 |
25.19 |
17.92 |
31.73 |
70.26 |
|
| Cash Earnings Retention Ratio (%) |
59.10 |
52.07 |
49.94 |
57.54 |
80.64 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
111,915.37 |
91,262.72 |
56,451.10 |
50,598.53 |
47,325.28 |
|
| EV/Net Operating Revenue (X) |
11.56 |
10.70 |
7.34 |
7.50 |
7.34 |
|
| EV/EBITDA (X) |
31.02 |
30.62 |
22.16 |
21.95 |
20.49 |
|
| MarketCap/Net Operating Revenue (X) |
11.31 |
10.32 |
6.76 |
7.02 |
6.67 |
|
| Retention Ratios (%) |
42.63 |
25.18 |
17.91 |
31.72 |
70.25 |
|
| Price/BV (X) |
14.42 |
12.89 |
8.06 |
7.46 |
7.13 |
|
| Price/Net Operating Revenue |
11.31 |
10.32 |
6.76 |
7.02 |
6.67 |
|
| Earnings Yield |
0.02 |
0.02 |
0.02 |
0.02 |
0.03 |
|
Source : Dion Global Solutions Limited
